Pharmaceutical compositions are suitable for systemic administration or for topical administration.

The composition for oral administration is highly safe and is suitable for long term administration.

The pharmaceutical compositions may be formulated for oral administration, transdermal administration, or injection.

The derivatives are suitable for oral administration.

The nutritional compositions are suitable for enteral delivery as a nutritional supplement or for oral delivery as a human milk or infant formula fortifier.

It is intended to provide a novel dry powder inhalation system for transpulmonary administration which is suitable for transpulmonary administration.

Disclosed are a DNA damage repair promoter for oral application and an elastase activity inhibitor for oral application.

Compositions may also be formaulated for transdermal administration.

The invention concerns novel antithrombotic formulations for subcutaneous administration.

The present invention relates to compositions for oral administration.

The methods and patches of the invention comprise: (1) a local-anesthetic component for local delivery of a local anesthetic; and (2) an opioid component for transdermal delivery of an opioid.

A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed.

Also provided is a method for making the oral pouch product (100).

The present invention provides implantable ocular drug delivery devices.

Carriers and excipients may be formulated for topical administration.